One year of daily Daybue (trofinetide) treatment led to improvements in behaviors such as nonverbal communication, alertness, and social interaction and connectedness among children and adults with Rett syndrome. That’s according to published interim data from Acadia Pharmaceuticals‘ Phase 4 LOTUS study that assessed the safety and effectiveness of the approved oral therapy in 227 […] The post Daybue shows real-world benefits for Rett syndrome patients: Study appeared first on Rett Synd...| Rett Syndrome News – The Web's Daily Resource for Rett Syndrome News
What is paraverbal communication and the importance of paraverbal communication in the workplace. Body language & non-verbal communioation.| Symonds Research